Significant fibrosis, as measured by FibroScan, was independently linked to type 2 diabetes in patients with metabolic dysfunction-associated steatotic liver disease.
Patients with severe sickle cell disease could soon be freed from vaso-occlusive crises after receiving an infusion of exa-cel, the first gene-editing therapy to use CRISPR technology.
Decreasing blood supply use could also preserve blood products for patients undergoing cancer treatment or surgery and for those with trauma or other illnesses.
Shorter colorectal cancer screening intervals may be appropriate for patients with higher fecal hemoglobin concentrations on fecal immunochemical testing.